The View’s Joy Behar Is Furious TrumpRX Is Lowering Drug Costs
Joy Behar of The View expressed outrage over President Trump's TrumpRX program aimed at lowering prescription drug costs. The initiative is set to expand access to 600 additional generic medications, potentially saving consumers significant amounts over the next decade. Critics argue that market-oriented reforms are often viewed with skepticism, while government-controlled healthcare proposals receive more favorable treatment.
- ▪Joy Behar suggested that lowering drug prices could be dangerous for Americans.
- ▪The TrumpRX program aims to add 600 generic medications to lower costs for consumers.
- ▪Critics highlight the complexities and potential downsides of government intervention in drug pricing.
Opening excerpt (first ~120 words) tap to expand
One day, historians may look back at The View and conclude the program functioned less as political commentary and more as accidental satire.That conclusion became even more plausible last week after co-host Joy Behar suggested Americans could effectively “die” because President Trump is attempting to lower prescription drug costs through the TrumpRX program.Yes — lower drug prices are apparently now dangerous.Yes — lower drug prices are apparently now dangerous.The outrage followed the administration’s announcement last Monday that roughly 600 additional generic medications would be added to the TrumpRX initiative, expanding access to lower-cost purchasing options for millions of Americans.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The American Spectator | USA News and Politics.
Discussion
0 comments
